Laura Lalaguna

6PUBLICATIONS
34CO-AUTHORS
Molecular targetsMedical devicesMechanobiologyMedical biochemistry - amino acids and metabolitesNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 04, 2026
Cardiomyocyte-Specific Inhibition of p53 Signaling as a Therapeutic Strategy for Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

|Mar 31, 2025
Paternal Cardiac Lesion Induces Cardiac Adaptation in Offspring.

Benedetta Coppe, María Galardi-Castilla, Andrés Sanz-Morejón

|Mar 17, 2025
Overexpression of Wild-Type TMEM43 Improves Cardiac Function in Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Laura Lalaguna, María Arévalo-Núñez de Arenas, Marina López-Olañeta

|Mar 04, 2024
Biallelic Loss of Function Variants in Myocardial Zonula Adherens Protein Gene (MYZAP) Cause a Severe Recessive Form of Dilated Cardiomyopathy.

Juan Pablo Ochoa, Laura Lalaguna, Jesús G Mirelis

|May 30, 2023
Titin Missense Variants as a Cause of Familial Dilated Cardiomyopathy.

Fernando Domínguez, Laura Lalaguna, Inés Martínez-Martín

|Aug 20, 2021
Early Preventive Treatment With Enalapril Improves Cardiac Function and Delays Mortality in Mice With Arrhythmogenic Right Ventricular Cardiomyopathy Type 5.

Fernando Domínguez, Laura Lalaguna, Marina López-Olañeta

Pageof 1

Frequent Collaborators

6 joint publications

Enrique Lara-Pezzi

5 joint publications

Pablo García-Pavía

3 joint publications

Fernando Domínguez

2 joint publications

Esther Zorio